Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shusuke Akamatsu

Showing results (101-110 of 216) with videos related to

Pageof 22
Sort By:
Cancer Science|January 5, 2023
Genetic variations predicting progression with docetaxel and novel androgen-receptor pathway inhibitorsMasaki Shiota, Shusuke Akamatsu, Yuya Sekine, et al.
Urology Journal|March 7, 2016
A Prospective Randomized Trial Comparing a Combined Regimen of Amikacin and Levofloxacin to Levofloxacin Alone as Prophylaxis in Transrectal Prostate Needle BiopsyYu Miyazaki, Shusuke Akamatsu, Sojun Kanamaru, et al.
International Journal of Clinical Oncology|August 17, 2024
A retrospective study of prognostic factors and prostate-specific antigen dynamics in Japanese patients with metastatic hormone-sensitive prostate cancer who received combined androgen blockade therapy with bicalutamideYu Tashiro, Shusuke Akamatsu, Kentaro Ueno, et al.
Hinyokika Kiyo. Acta Urologica Japonica|December 22, 2024
[Clinical Study of Lymph Node Dissection in Robot-Assisted Radical Prostatectomy for High-Risk Prostate Cancer]Shotaro Hatano, Takayuki Goto, Jin Kono, et al.
Cancer Science|July 30, 2021
High level of phosphatidylcholines/lysophosphatidylcholine ratio in urine is associated with prostate cancerXin Li, Kenji Nakayama, Takayuki Goto, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 3, 2021
Long-term clinical outcomes of external beam radiation therapy for oligometastatic prostate cancer: A combination of prostate-targeted treatment and metastasis-directed therapyRihito Aizawa, Kenji Takayama, Kiyonao Nakamura, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 2, 2025
Response to First-Line Chemotherapy Predicts Response to Maintenance Avelumab Therapy in Japanese Patients With Advanced Urothelial CarcinomaSatoshi Inoue, Akira Hayakawa, Mikinori Kobayashi, et al.
BMC Urology|August 22, 2020
Cognitive behavioral therapy for overactive bladder in women: study protocol for a randomized controlled trialSatoshi Funada, Norio Watanabe, Takayuki Goto, et al.
BMC Urology|May 14, 2021
Protocol for development and validation of a prediction model for 5-year risk of incident overactive bladder in the general population: the Nagahama studySatoshi Funada, Yan Luo, Takashi Yoshioka, et al.
Cancer Medicine|October 27, 2020
Functional and genomic characterization of patient-derived xenograft model to study the adaptation to mTORC1 inhibitor in clear cell renal cell carcinomaHiromasa Sakamoto, Toshinari Yamasaki, Takayuki Sumiyoshi, et al.
Pageof 22

Showing results (101-110 of 216) with videos related to

Sort By:
Pageof 22
Cancer Science|January 5, 2023
Genetic variations predicting progression with docetaxel and novel androgen-receptor pathway inhibitorsMasaki Shiota, Shusuke Akamatsu, Yuya Sekine, et al.
Urology Journal|March 7, 2016
A Prospective Randomized Trial Comparing a Combined Regimen of Amikacin and Levofloxacin to Levofloxacin Alone as Prophylaxis in Transrectal Prostate Needle BiopsyYu Miyazaki, Shusuke Akamatsu, Sojun Kanamaru, et al.
International Journal of Clinical Oncology|August 17, 2024
A retrospective study of prognostic factors and prostate-specific antigen dynamics in Japanese patients with metastatic hormone-sensitive prostate cancer who received combined androgen blockade therapy with bicalutamideYu Tashiro, Shusuke Akamatsu, Kentaro Ueno, et al.
Hinyokika Kiyo. Acta Urologica Japonica|December 22, 2024
[Clinical Study of Lymph Node Dissection in Robot-Assisted Radical Prostatectomy for High-Risk Prostate Cancer]Shotaro Hatano, Takayuki Goto, Jin Kono, et al.
Cancer Science|July 30, 2021
High level of phosphatidylcholines/lysophosphatidylcholine ratio in urine is associated with prostate cancerXin Li, Kenji Nakayama, Takayuki Goto, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 3, 2021
Long-term clinical outcomes of external beam radiation therapy for oligometastatic prostate cancer: A combination of prostate-targeted treatment and metastasis-directed therapyRihito Aizawa, Kenji Takayama, Kiyonao Nakamura, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 2, 2025
Response to First-Line Chemotherapy Predicts Response to Maintenance Avelumab Therapy in Japanese Patients With Advanced Urothelial CarcinomaSatoshi Inoue, Akira Hayakawa, Mikinori Kobayashi, et al.
BMC Urology|August 22, 2020
Cognitive behavioral therapy for overactive bladder in women: study protocol for a randomized controlled trialSatoshi Funada, Norio Watanabe, Takayuki Goto, et al.
BMC Urology|May 14, 2021
Protocol for development and validation of a prediction model for 5-year risk of incident overactive bladder in the general population: the Nagahama studySatoshi Funada, Yan Luo, Takashi Yoshioka, et al.
Cancer Medicine|October 27, 2020
Functional and genomic characterization of patient-derived xenograft model to study the adaptation to mTORC1 inhibitor in clear cell renal cell carcinomaHiromasa Sakamoto, Toshinari Yamasaki, Takayuki Sumiyoshi, et al.
Pageof 22